Advanced search×

Effects of atenolol and propanolol on platelet aggregation in moderate essential hypertension.

Cengiz Beyan, Kürşat Kaptan, and Ahmet Ifran

Croat Med J 46(4):695-6; author reply 696-7 (2005) PMID 16161254

Version: za2963e q8zac q8zba q8zcf q8zd0 q8ze4 q8zfe q8zg6
PDF not found

Similar articles you may find interesting…

  1. Effects of atenolol and propranolol on platelet aggregation in moderate essential hypertension: randomized crossover trial.
    Ante A Punda, Stojan S Polić, ... Ajvor A Lukin

    Croat Med J 46(2):219-24 (2005) PMID 15849842

    There were no significant differences in creatinine, blood glucose, potassium, total cholesterol, hemoglobin, red blood cells (RBC), or platelets in three periods: baseline, atenolol, and propranolol period. Significant and comparable reductions in systolic and diastolic arterial pressure, body weig...
    PDF not found
  2. Should medical treatment options be exhausted before splenectomy is performed in adult ITP patients? A debate.
    Roberto Stasi, Adrian Newland, ... Ingrid Pabinger

    Ann Hematol 89(12):1185-95 (2010) PMID 20842501

    Patients with primary immune thrombocytopenia (ITP) may require treatment to reduce the risk of serious bleeding if platelets remain consistently below 30 × 10(9)/L. While approximately 70-80% of patients respond to an initial course of corticosteroids, relapse is common. For st...
  3. Efficient and targeted delivery of siRNA in vivo.
    Min Suk Shim and Young Jik Kwon

    FEBS J 277(23):4814-27 (2010) PMID 21078116